UTI director buys 1,000 shares at $25.945 average
Universal Technical Institute Inc. director Robert Thomas Devincenzi purchased 1,000 shares of common stock in an open-market transaction on August 12, 2026 at a weighted average price of $25.945 per share, increasing his direct holdings to 149,330 shares.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Universal Technical Institute Inc. director Robert Thomas Devincenzi purchased 1,000 shares of common stock in an open-market transaction on August 12, 2026 at a weighted average price of $25.945 per share, increasing his direct holdings to 149,330 shares. The shares were acquired in multiple trades within a price range of $25.91–$25.98.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock, $0.0001 par value F1 | 1,000 | $25.945 | $26K |
Footnotes (1)
- F1. The prices reported in Column 4 reflect a weighted average price. These shares were purchased in multiple transactions at prices ranging from $25.91 to $25.98. The reporting person undertakes to provide to the issuer or to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth herein.
Key Figures
Key Terms
weighted average price financial
open market or private transaction financial
par value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did UTI director Robert Thomas Devincenzi report?
Was the recent UTI insider trade a purchase or a sale?
How were the transaction prices for the UTI insider purchase determined?
AI-generated analysis. How Rhea-AI works. Not financial advice.